chr4-108009883-T-C
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005327.7(HADH):c.257T>C(p.Leu86Pro) variant causes a missense change. The variant allele was found at a frequency of 0.914 in 1,607,364 control chromosomes in the GnomAD database, including 674,453 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.87 ( 57994 hom., cov: 29)
Exomes 𝑓: 0.92 ( 616459 hom. )
Consequence
HADH
NM_005327.7 missense
NM_005327.7 missense
Scores
18
Clinical Significance
Conservation
PhyloP100: 4.87
Genes affected
HADH (HGNC:4799): (hydroxyacyl-CoA dehydrogenase) This gene is a member of the 3-hydroxyacyl-CoA dehydrogenase gene family. The encoded protein functions in the mitochondrial matrix to catalyze the oxidation of straight-chain 3-hydroxyacyl-CoAs as part of the beta-oxidation pathway. Its enzymatic activity is highest with medium-chain-length fatty acids. Mutations in this gene cause one form of familial hyperinsulinemic hypoglycemia. The human genome contains a related pseudogene of this gene on chromosome 15. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=7.211664E-7).
BP6
Variant 4-108009883-T-C is Benign according to our data. Variant chr4-108009883-T-C is described in ClinVar as [Benign]. Clinvar id is 167162.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-108009883-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.949 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HADH | NM_005327.7 | c.257T>C | p.Leu86Pro | missense_variant | Exon 2 of 8 | ENST00000309522.8 | NP_005318.6 | |
HADH | NM_001184705.4 | c.257T>C | p.Leu86Pro | missense_variant | Exon 2 of 9 | NP_001171634.3 | ||
HADH | NM_001331027.2 | c.269T>C | p.Leu90Pro | missense_variant | Exon 2 of 8 | NP_001317956.2 | ||
HADH | XR_007096395.1 | n.301T>C | non_coding_transcript_exon_variant | Exon 2 of 8 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.867 AC: 131686AN: 151928Hom.: 57953 Cov.: 29
GnomAD3 genomes
AF:
AC:
131686
AN:
151928
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.921 AC: 231638AN: 251446Hom.: 107303 AF XY: 0.921 AC XY: 125166AN XY: 135906
GnomAD3 exomes
AF:
AC:
231638
AN:
251446
Hom.:
AF XY:
AC XY:
125166
AN XY:
135906
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.919 AC: 1338010AN: 1455316Hom.: 616459 Cov.: 34 AF XY: 0.919 AC XY: 665677AN XY: 724400
GnomAD4 exome
AF:
AC:
1338010
AN:
1455316
Hom.:
Cov.:
34
AF XY:
AC XY:
665677
AN XY:
724400
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.867 AC: 131787AN: 152048Hom.: 57994 Cov.: 29 AF XY: 0.871 AC XY: 64705AN XY: 74320
GnomAD4 genome
AF:
AC:
131787
AN:
152048
Hom.:
Cov.:
29
AF XY:
AC XY:
64705
AN XY:
74320
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
3398
ALSPAC
AF:
AC:
3546
ESP6500AA
AF:
AC:
3104
ESP6500EA
AF:
AC:
7944
ExAC
AF:
AC:
111095
Asia WGS
AF:
AC:
3211
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
May 16, 2017
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Deficiency of 3-hydroxyacyl-CoA dehydrogenase Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;.;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T;T;T
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N;N;.;.
PrimateAI
Benign
T
PROVEAN
Benign
.;.;N;N;.
REVEL
Benign
Sift
Benign
.;.;T;T;.
Sift4G
Benign
.;T;T;.;T
Polyphen
0.0
.;.;B;.;.
Vest4
0.050, 0.047, 0.074
MPC
0.38
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at